How Do You Run Google Ads for a GLP-1 Telehealth Brand?

Certification comes before everything

Google restricts the promotion of telemedicine services and prescription medication to certified advertisers. MedScale works only with telehealth brands, and the operational consequence is that no amount of campaign work produces delivery until the account is certified.

Teams frequently discover this after building out a full account structure. The account is technically complete, nothing serves, and the diagnosis is mistaken for a bidding or quality problem for weeks.

The landing page carries more weight here than on social

Google evaluates the destination closely in healthcare categories, and in GLP-1 specifically the page usually carries more regulatory language than the ad does. Product descriptions, pricing comparisons, and claims about formulations tend to live on the page rather than in a headline.

• Outcome claims stated without qualification, particularly specific weight loss figures.
• Pricing comparisons whose basis depends on supply arrangements that may have changed.
• Product descriptions that overstate what a patient is guaranteed to receive.
• Missing or unclear information about the clinical process and who is eligible.

Search intent in this category is unusually mixed

GLP-1 search demand spans people researching a medication, people looking for a specific brand they cannot be supplied, people comparing prices, and people ready to start a clinical programme. Only the last group is worth much to a telehealth brand, and undifferentiated keyword expansion buys mostly the others.

The discipline that matters is negative keywords and intent segmentation, applied earlier than feels comfortable. An account that scales volume before separating those intents will show improving traffic and deteriorating economics at the same time.

Measuring the right conversion

The most common structural error in GLP-1 search accounts is optimising to an early funnel event. Intake starts are plentiful and cheap, and they correlate weakly with treated patients in a category with meaningful clinical screening and a real price point.

MedScale builds toward an event that reflects genuine clinical intent and still occurs often enough to train delivery. The choice of that event does more for account economics than bid strategy usually does.

Ad copy has less room than social creative

Search headlines are short, which removes the space that makes compliant messaging comfortable on social. A thirty-character headline cannot easily carry a mechanism explanation, so the pressure to compress into an outcome claim is considerable.

The workable pattern is to let the headline carry the service and the description carry the qualification, rather than attempting to fit both into the headline. MedScale writes GLP-1 search copy so that no single asset asserts an outcome on its own, since assets are recombined automatically and a compliant pair can produce a non-compliant combination.

That last point catches teams repeatedly. Responsive search ads mix headlines and descriptions independently, so every asset has to stand alone under review rather than relying on a neighbouring asset to qualify it.

What to do when disapprovals appear anyway

The first diagnostic question is whether the disapprovals are isolated or account-wide. Account-wide disapprovals almost always indicate a certification or policy status change rather than a creative problem, and rewriting ads in that situation produces new ads that fail identically.

Where disapprovals are isolated, the cited policy is the useful signal. A cluster under one policy indicates a systemic issue in how the ads or pages are built, and should be fixed at the template rather than one unit at a time.